faers
Semaglutide vs Tirzepatide - Alopecia Cost Uncovered
A 12% spike in high-dose tirzepatide patients aged 45-60 triggered a decade-long surge in alopecia reports. The condition adds roughly $42,500 per case to health-care budgets and pushes annual drug-therapy expenses up by $1,250 per patient. Medical Disclaimer: This article is for informational purposes only and does not